Atritech
WATCHMAN™ Left Atrial Appendage Closure Device | Warfarin Therapy Alternative | Boston Scientific.
Launch date
Market cap
-
Enterprise valuation
€341m (Public information from Jan 2011)
Plymouth United States (HQ)
| Date | Investors | Amount | Round |
|---|---|---|---|
| - | N/A | - | |
| N/A | $8.7m | Series B | |
$22.0m | Series D | ||
$30.0m | Late VC | ||
$375m Valuation: $375m | Acquisition | ||
| Total Funding | €55.2m | ||
